Determinants of persistent detection of human papillomavirus DNA in the uterine cervix

The Journal of Infectious Diseases
J BrissonA Meisels

Abstract

To identify factors associated with persistence of human papillomavirus (HPV) DNA in the uterine cervix, 179 women who were 18-49 years old and who had normal cytologies and positive cervical HPV DNA test at a routine periodic examination were analyzed. Among them, 91 (50.8%) remained HPV-positive a few months (mean, 11 weeks) later. Persistence was higher in women who had used oral contraceptives for > or = 2 years (odds ratio, 3.9; 95% confidence interval, 1.5-10.3) compared with those who never used oral contraceptives or used them for <2 years. HPV types 16, 18, and 31/33/35 appeared more persistent (odds ratio, 2.5; 95% confidence interval, 1.0-6.2) than other types. Persistence seemed to increase with virus load and decrease with increasing interval between examinations.

Citations

Feb 15, 2002·BJOG : an International Journal of Obstetrics and Gynaecology·J M Kirwan, C S Herrington
Dec 4, 2003·Cancer Detection and Prevention·Elaine M SmithLubomir P Turek
Feb 12, 1998·The New England Journal of Medicine·G Y HoR D Burk
Dec 21, 2004·The Journal of Infectious Diseases·Darron R BrownJ Dennis Fortenberry
Nov 17, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marjut A M RintalaStina M Syrjänen
Jul 26, 2013·The Journal of Infectious Diseases·Su-Hsun LiuDerek A T Cummings
Oct 3, 2002·Journal of the National Cancer Institute·Jeanne S MandelblattPaul D Blumenthal
Dec 24, 2003·The Cancer Journal·Eduardo L FrancoDebbie Saslow
Jul 9, 2010·Current Opinion in Oncology·Mark H Einstein, Rébécca Phaëton
Sep 22, 2005·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·M E ScheurerK Adler-Storthz
Jan 23, 1999·Infectious Diseases in Obstetrics and Gynecology·A L DistéfanoA Teyssié
Dec 22, 2010·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Rachel L WinerLaura A Koutsky
Apr 19, 2011·Clinical Medicine Insights. Oncology·Jimmy T EfirdChristopher J Phillips
Oct 1, 2008·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Jennifer S SmithJeanne M Pimenta
Sep 15, 2007·Gynécologie, obstétrique & fertilité·G RobinB Letombe
Sep 11, 2012·International Journal of Cancer. Journal International Du Cancer·Anne F RositchJennifer S Smith
Feb 19, 2010·Journal of Medical Virology·Ann NielsenThomas Iftner
Jan 13, 2006·Vaccine·Helen Trottier, Eduardo L Franco
Jul 27, 2005·Seminars in Pediatric Infectious Diseases·Marcia L Shew, J Dennis Fortenberry
Sep 19, 2000·American Journal of Obstetrics and Gynecology·K ElfgrenJ Dillner
Mar 18, 1999·Hematology/oncology Clinics of North America·G Tortolero-Luna
Aug 13, 2008·The Journal of Infectious Diseases·Laura K SycuroLaura A Koutsky
Apr 30, 2002·Current Opinion in Infectious Diseases·D Jenkins
Jul 20, 2002·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·E M SmithL P Turek
Jun 4, 2010·Revista brasileira de enfermagem·Janete Tamani Tomiyoshi NakagawaMárcia Barbieri

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.